Mannose-binding lectin is a component of innate mucosal defense against Cryptosporidium parvum in AIDS

被引:76
作者
Kelly, P
Jack, DL
Naeem, A
Mandanda, B
Pollok, RCG
Klein, NJ
Turner, MW
Farthing, MJG
机构
[1] St Bartholomews & Royal London Sch Med & Dent, Digest Dis Res Ctr, London E1 2AD, England
[2] UCL, Inst Child Hlth, Immunol Unit, London, England
[3] Univ Zambia, Sch Med, Lusaka, Zambia
基金
英国惠康基金;
关键词
D O I
10.1053/gast.2000.19573
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Nonimmune mechanisms of mucosal defense seem to be biologically important and might explain the observed variability in the course of enteric infection in immunodeficiency, Mannose-binding lectin (MBL) deficiency is associated with persistent diarrhea in children, We found that genetic determinants of MBL deficiency appear to predispose to cryptosporidiosis in patients with the acquired immunodeficiency syndrome (AIDS), and went on to study interactions of MBL and complement on Cryptosporidium parvum sporozoites. Methods: This study involved cross-sectional study of MBL genotype and enteric infection in 72 Zambian AIDS patients with diarrhea, immunofluorescence analysis of MBL and C4 binding to C. parvum, and immunoblotting for MBL and complement in small intestinal fluid, Results: individuals homozygous for MBL structural gene mutations were at increased risk of cryptosporidiosis (odds ratio, 8.2; 95% confidence interval, 1.5-42; P = 0.02). Lectin-mediated and concentration-dependent binding of purified MBL was detected on sporozoites but not oocysts, and MBL activated C4 on sporozoites, MEL, C3, C4, and albumin were detected in small intestinal fluid in half the patients tested, suggesting transexudation of serum components into the enteropathic gut, Conclusions: The increased risk of cryptosporidiosis in MEL deficiency appears to include patients with AIDS. It may operate through MEL-mediated complement activation on sporozoites.
引用
收藏
页码:1236 / 1242
页数:7
相关论文
共 36 条
[1]   INEFFICACY OF INTESTINAL SECRETORY IMMUNE-RESPONSE TO CRYPTOSPORIDIUM IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
BENHAMOU, Y ;
KAPEL, N ;
HOANG, C ;
MATTA, H ;
MEILLET, D ;
MAGNE, D ;
RAPHAEL, M ;
GENTILINI, M ;
OPOLON, P ;
GOBERT, JG .
GASTROENTEROLOGY, 1995, 108 (03) :627-635
[2]  
BLANSHARD C, 1992, Q J MED, V85, P813
[3]   A HUMAN-SERUM MANNOSE-BINDING PROTEIN INHIBITS INVITRO INFECTION BY THE HUMAN IMMUNODEFICIENCY VIRUS [J].
EZEKOWITZ, RAB ;
KUHLMAN, M ;
GROOPMAN, JE ;
BYRN, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (01) :185-196
[4]   CRYPTOSPORIDIUM INFECTION AND CD4 COUNTS [J].
FLANIGAN, T ;
WHALEN, C ;
TURNER, J ;
SOAVE, R ;
TOERNER, J ;
HAVLIR, D ;
KOTLER, D .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (10) :840-842
[5]   Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin [J].
Garred, P ;
Madsen, HO ;
Balslev, U ;
Hofmann, B ;
Pedersen, C ;
Gerstoft, J ;
Svejgaard, A .
LANCET, 1997, 349 (9047) :236-240
[6]  
GARRED P, 1993, CLIN EXP IMMUNOL, V94, P99
[7]  
Holmskov U, 1993, Behring Inst Mitt, P224
[8]  
Jack D, 1997, HUM MUTAT, V9, P41, DOI 10.1002/(SICI)1098-1004(1997)9:1<41::AID-HUMU7>3.3.CO
[9]  
2-W
[10]  
Jack DL, 1998, J IMMUNOL, V160, P1346